We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current XTNT market cap is 88.56M. The company's latest EPS is USD 0.0051 and P/E is 133.33.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 17.94M | 20.23M | 25.02M | 28.11M | 27.87M |
| Operating Income | -1.58M | -1.39M | -3.39M | -3.81M | -3.47M |
| Net Income | -2.08M | -2.19M | 9.23M | -4.3M | -4.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 64.68M | 53.34M | 55.26M | 57.97M | 91.3M |
| Operating Income | -2.25M | -751k | -3.85M | -6.76M | -10.16M |
| Net Income | -8.22M | -7.02M | -4.85M | -8.49M | 660k |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 63.32M | 65.22M | 92M | 92.61M | 93.93M |
| Total Liabilities | 30.61M | 34.26M | 37.32M | 41.26M | 46.25M |
| Total Equity | 32.71M | 30.96M | 54.68M | 51.35M | 47.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.16M | 41.47M | 54.69M | 60.23M | 92.61M |
| Total Liabilities | 87.36M | 26.95M | 23.81M | 26.06M | 41.26M |
| Total Equity | -44.21M | 14.51M | 30.88M | 34.17M | 51.35M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.25M | -4.77M | -8.6M | -9.52M | -5.76M |
| Investing | -17.42M | -17.82M | -22.47M | -24.78M | -674k |
| Financing | 4.57M | 6.52M | 19.37M | 19.69M | 5.18M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -413k | -731k | 439k | -5.34M | -9.52M |
| Investing | -544k | -1.3M | -1.89M | -1.56M | -24.78M |
| Financing | -603k | -861k | 17.5M | 9.02M | 19.69M |
| Market Cap | 88.56M |
| Price to Earnings Ratio | 133.33 |
| Price to Sales Ratio | 0.97 |
| Price to Cash Ratio | 15.49 |
| Price to Book Ratio | 1.72 |
| Dividend Yield | - |
| Shares Outstanding | 130.22M |
| Average Volume (1 week) | 45.98k |
| Average Volume (1 Month) | 69.77k |
| 52 Week Change | -20.13% |
| 52 Week High | 1.45 |
| 52 Week Low | 0.6784 |
| Spread (Intraday) | 0.21 (23.33%) |
| Company Name | Xtant Medical Holdings Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://xtantmedical.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
